Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction Primary Results of the FABOLUS-FASTER Trial

Gargiulo, G; Esposito, G; Avvedimento, M; Nagler, M; Minuz, P; Campo, G; Gragnano, F; Manavifar, N; Piccolo, R; Tebaldi, M; Cirillo, P; Hunziker, L; Vranckx, P; Leonardi, S; Heg, D; Windecker, S; Valgimigli, M

Valgimigli, M (corresponding author), Bern Univ Hosp, Freiburgstr 10, CH-3010 Bern, Switzerland.

CIRCULATION, 2020; 142 (5): 441

Abstract

BACKGROUND: Standard administration of newer oral P2Y(12)inhibitors, including prasugrel or ticagrelor, provides suboptimal early inhibition of platel......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索